ResearcherFudan UniversityActive in the last 2 years

Doctor Xianjun Yu

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 6 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 2 (principal investigator on 2)
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2022: 1 trial · 2023: none · 2024: none · 2025: none · 2026: 1 trial

Trials 2

A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) Principal investigator NCT07417189 ↗
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001） Principal investigator NCT05707676 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Doctor Jian Zhang · 1 shared trial, 2022 · strength 0.49
- Trial A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced S… NCT05707676 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.